• Home
  • About
    • Overview
    • Sharing Data
    • ORCID
  • Help
  • History (1)
    • Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.
    • See All Pages
  • search
    • Find People
    • Find Everything
Login to edit your profile (add a photo, awards, links to other websites, etc.)
  • Edit My Profile
  • My Person List (0)

Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome.

Simvastatin inhibits LPS-induced alveolar bone loss during metabolic syndrome. J Dent Res. 2014 Mar; 93(3):294-9.

View in: PubMed

subject areas
  • Aggregatibacter actinomycetemcomitans
  • Alveolar Bone Loss
  • Animals
  • Anti-Inflammatory Agents
  • Blood Glucose
  • Chemotaxis, Leukocyte
  • Cholesterol
  • Disease Models, Animal
  • Fatty Acids, Nonesterified
  • Female
  • Granulocyte-Macrophage Colony-Stimulating Factor
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Insulin
  • Insulin Resistance
  • Interleukin-6
  • Leukocytes
  • Lipopolysaccharides
  • Metabolic Syndrome
  • Osteoclasts
  • Palmitic Acid
  • Periodontitis
  • RANK Ligand
  • Rats
  • Rats, Zucker
  • Simvastatin
  • Triglycerides
  • X-Ray Microtomography

authors with profiles
  • Maria F Lopes-Virella
  • Hong Yu